Bringing the fundamentals into focus…
Back to Artiva Biotherapeutics, Inc.
How Artiva Biotherapeutics, Inc. stacks up
ARTV · against 243 other Healthcare companies of similar size
Profitability
11/ 100
Near the bottom of its peers.
Ranked #195 of 244 · scores higher than 19% of peers
Bars: peers in each 10-point band of the profitability score37 peers with a profitability score of 10–19, including ARTV · Click a bar to see the companies
Why profitability scores 11?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on invested capital and return on assets, which are weaker than most Healthcare peers.
- a lower return on invested capital: weaker than 95% of peers. Return on invested capital: -165.0% vs peer median 4.7%
- a lower return on assets: weaker than 84% of peers. Return on assets: -24.6% vs peer median 1.7%
- Operating margin is not reported, so it is left out of the score.
Metric by metric
Position: dot = ARTV, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ARTV | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 204 reported | -165.0% | -2.4% | 8% | 33% | |
| Operating marginHigher is better · 224 reported | Not reported | 0.7% | — | — | 33% |
| Return on assetsHigher is better · 248 reported | -24.6% | -1.9% | 26% | 33% | |
| Return on equityHigher is better · 230 reported | -36.6% | -4.8% | 28% | Context only | |
| Gross marginHigher is better · 261 reported | 0.0% | 38.1% | 7% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around ARTV| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 261M USD | 98 | 97 | |
| 2 | 1.4B HKD (≈$181M) | 97 | 61 | |
| 2 | 356M AUD (≈$235M) | 97 | 81 | |
| 4 | 592M ILS (≈$160M) | 96 | 84 | |
| 5 | 301M USD | 95 | 67 | |
| 190 | 388M USD | 12 | 36 | |
| 190 | 217M AUD (≈$143M) | 12 | 43 | |
| 190 | 227M USD | 12 | 24 | |
| 195 | 1.8B HKD (≈$236M) | 11 | ||
| 195 | 205M USD | 11 | 36 | |
| 195 | 117M USD | 11 | 40 | |
| 195 | 284M AUD (≈$188M) | 11 | 36 | |
| 199 | 7.2B TWD (≈$224M) | 10 | 41 | |
| 199 | 377M USD | 10 | 29 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score